The interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to reflect latest evidence.
For further information, see below:
source https://www.who.int/news/item/30-07-2021-updated-recommendations-for-use-of-the-chadox1-s-recombinant-vaccine-against-covid-19
Tags
WHO News